Mastering Hematology for Your FNP Boards: High-Yield Concepts & Clinical Pearls

Hematology · 7 min read · August 8, 2026

Mastering Hematology for Your FNP Boards: High-Yield Concepts & Clinical Pearls

Feeling a little overwhelmed by hematology as you prepare for your FNP board exams? You're not alone! The study of blood and its disorders can seem vast, but with a focused approach, you can master the high-yield concepts that are crucial for both the AANP and ANCC exams. Dr. Orlando Debesa and The FNP Review are here to help you cut through the noise and build the confidence you need to succeed.

Hematology is a cornerstone of primary care, meaning you'll encounter these conditions frequently in practice and on your boards. We'll break down the most common and board-relevant hematologic disorders, focusing on what you absolutely need to know for diagnosis and management.

Anemias: Your Bread and Butter

Anemia is arguably the most common hematologic abnormality you'll see, both in clinical practice and on your board exam. It's not a diagnosis in itself, but rather a sign of an underlying issue. Your job as an FNP is to identify the type of anemia and, more importantly, its cause.

Iron Deficiency Anemia (IDA)

Pathophysiology: IDA results from insufficient iron to produce adequate hemoglobin. This can be due to chronic blood loss (most common cause worldwide and in adults), decreased absorption, or increased demand (e.g., pregnancy).

Key Findings:

CBC: Microcytic (low MCV), hypochromic (low MCH/MCHC) red blood cells.
Iron Studies: Low serum iron, low ferritin (the most sensitive indicator of iron stores), high Total Iron Binding Capacity (TIBC), and low transferrin saturation.
Symptoms: Fatigue, pallor, glossitis (smooth tongue), angular cheilitis, pica (craving non-food items like ice), restless leg syndrome, and koilonychia (spoon-shaped nails) in severe cases.

Management:

First-line: Oral iron supplementation (ferrous sulfate is commonly used).
Patient Education: Advise taking iron with Vitamin C (like orange juice) to enhance absorption and on an empty stomach if tolerated. Avoid taking with antacids, coffee, or tea.
Monitoring: Reticulocyte count should increase within 5-7 days of starting iron. Hemoglobin levels should improve within a few weeks, but full repletion of stores can take several months.
Address the Cause: Always investigate and treat the underlying cause of blood loss.

Clinical Pearl: Ferritin is an acute-phase reactant. This means that in the presence of inflammation, infection, or malignancy, ferritin levels can appear normal even if the patient is truly iron deficient. If you suspect IDA but ferritin is borderline, consider checking a C-reactive protein (CRP) or transferrin saturation to get a clearer picture.

Vitamin B12 Deficiency Anemia (Pernicious Anemia)

Pathophysiology: Often caused by impaired absorption due to lack of intrinsic factor (pernicious anemia), gastric surgery, or strict vegan diets. B12 is crucial for DNA synthesis and neurologic function.

Key Findings:

CBC: Macrocytic (high MCV), normochromic anemia. Pancytopenia can also occur.
Symptoms: Classic triad includes weakness, sore tongue (glossitis), and paresthesias/neurologic symptoms (e.g., numbness, tingling, gait disturbance). Neurologic symptoms are a key differentiator from folate deficiency.
Labs: Low serum B12 levels. May also have elevated methylmalonic acid (MMA) and homocysteine levels.

Management:

Lifelong parenteral (IM) B12 replacement is the cornerstone of treatment for pernicious anemia to bypass the absorption issue.

Folate Deficiency Anemia

Pathophysiology: Often due to inadequate dietary intake, alcoholism, malabsorption (e.g., celiac disease), or increased demand (e.g., pregnancy).

Key Findings:

CBC: Macrocytic (high MCV), normochromic anemia.
Symptoms: Similar to B12 deficiency (fatigue, pallor, glossitis) but lacks neurologic symptoms.
Labs: Low serum folate, normal MMA, elevated homocysteine.

Management: Oral folate supplementation.

Coagulation Disorders: Bleeding and Clotting Concerns

Understanding the delicate balance of hemostasis is vital. Disorders can lead to excessive bleeding or inappropriate clotting.

Hemophilia

Pathophysiology: X-linked recessive bleeding disorder, primarily affecting males. Hemophilia A is a deficiency in Factor VIII, and Hemophilia B is a deficiency in Factor IX.

Key Findings:

Symptoms: Spontaneous bleeding, deep tissue hematomas, hemarthroses (bleeding into joints). Severity depends on factor levels.
Labs: Prolonged aPTT (reflects intrinsic pathway), normal PT/INR, normal bleeding time, normal platelet count. Specific factor assays confirm the diagnosis.

Management:

Factor Replacement Therapy: The mainstay of treatment, either on-demand for bleeding episodes or prophylactic to prevent them.
Patient Education: Avoid NSAIDs and aspirin due to their antiplatelet effects; acetaminophen is preferred for pain.

Board Tip: Remember the difference between primary and secondary hemostasis. Primary hemostasis involves platelets and presents with immediate bleeding (petechiae, purpura, mucosal bleeding). Secondary hemostasis involves clotting factors and presents with delayed, deeper bleeding (hematomas, hemarthroses). Hemophilia is a secondary hemostasis disorder.

Thrombocytopenia

Pathophysiology: A platelet count below 150,000/µL. Can result from decreased production (e.g., bone marrow suppression, B12/folate deficiency, certain medications, infections, malignancy), increased destruction (e.g., ITP, TTP, DIC), or sequestration (e.g., splenomegaly).

Key Findings:

Symptoms: Easy bruising, petechiae, purpura, nosebleeds, bleeding gums, heavy menstrual bleeding. Spontaneous bleeding risk increases significantly with platelet counts below 10,000-20,000/µL.

Management:

Address the underlying cause: This is paramount. Discontinue causative medications, treat infections, or manage underlying autoimmune conditions.
Immune Thrombocytopenic Purpura (ITP): Often follows a viral illness in children. Autoimmune destruction of platelets. Treatment may involve corticosteroids, IVIG, or splenectomy in severe/refractory cases.

Myeloproliferative Neoplasms: Too Many Cells

These are disorders where the bone marrow produces too many of one or more types of blood cells. For your boards, Polycythemia Vera (PV) is the most important to know.

Polycythemia Vera (PV)

Pathophysiology: A chronic myeloproliferative neoplasm characterized by an overproduction of all blood cell lines, especially red blood cells, due to a mutation (most commonly JAK2). This leads to increased blood viscosity and a higher risk of thrombosis.

Key Findings:

Symptoms: Often vague initially, including fatigue, headache, dizziness, pruritus (especially after warm water exposure – aquagenic pruritus), blurred vision, tinnitus, and plethora (ruddy complexion). Splenomegaly is common.
Complications: Increased risk of blood clots (stroke, DVT, PE), leading to significant morbidity and mortality.
Labs: Elevated hemoglobin, hematocrit, red blood cell count. White blood cells and platelets may also be elevated. Low erythropoietin levels. Presence of JAK2 mutation.

Management:

Phlebotomy: First-line treatment to reduce red blood cell mass and normalize hematocrit, thereby reducing blood viscosity and thrombosis risk.
Aspirin: Low-dose aspirin is often used to reduce the risk of arterial thrombosis.
Hydroxyurea: May be used in high-risk patients or those with elevated WBC/platelet counts.

Clinical Pearl: The classic symptom of aquagenic pruritus (itching after contact with water) is highly suggestive of Polycythemia Vera and is a common board exam question trigger.

Sickle Cell Disease: A Genetic Challenge

Pathophysiology: An autosomal recessive genetic disorder where normal hemoglobin A is replaced by hemoglobin S, leading to sickling of red blood cells under stress (e.g., hypoxia, dehydration, infection). These sickle cells are rigid, leading to vaso-occlusion, hemolysis, and chronic organ damage.

Key Findings:

Vaso-occlusive crises (VOCs): The most common and painful manifestation, caused by sickled cells obstructing blood flow. Pain can be severe and affect any body part.
Acute Chest Syndrome: A life-threatening complication characterized by fever, chest pain, and pulmonary infiltrates.
Increased Infection Risk: Due to splenic dysfunction (autosplenectomy).

Management (Acute Crisis):

Hydration: Crucial to reduce blood viscosity and prevent further sickling. IV fluids are often administered.
Pain Management: Aggressive pain control with opioids is essential, as VOC pain is severe.
Oxygen: Administer for hypoxia, but it does not reverse existing sickling.
Infection Control: Prompt antibiotics if infection is suspected.

Management (Chronic):

Hydroxyurea: Increases fetal hemoglobin (HbF), which prevents sickling and reduces crisis frequency. Recommended for most patients over 9 months.
Vaccinations & Prophylactic Penicillin: Essential to prevent infections, especially in children.
Transcranial Doppler (TCD) Screening: For children to assess stroke risk.

Board Tip: When managing a sickle cell crisis, remember the ABCs plus pain and hydration. Airway, Breathing, Circulation, then aggressive Pain management and Hydration.

Final Thoughts for Your Boards

Hematology questions on your FNP boards will often test your ability to differentiate between similar conditions based on key lab values, symptoms, and first-line treatments. Focus on understanding the why behind the pathophysiology and the how of management. Don't just memorize; strive to understand the clinical picture. You've put in the hard work, and you have the clinical reasoning skills to excel. Trust your knowledge, stay calm, and approach each question systematically. You've got this!

Ready to solidify your hematology knowledge and tackle even more high-yield topics? Visit thefnpreview.com for comprehensive board prep resources, including Q-banks, video lessons, and cheat sheets designed by Dr. Orlando Debesa to help you pass with confidence.